MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals board to consider financial results

18 Oct 2012 Evaluate
GlaxoSmithKline Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on November 09, 2012, to consider, approval of unaudited financial results for the quarter ended September 30, 2012 (Q3).

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1855.00
Dr. Reddys Labs. 1147.20
Cipla 1359.00
Lupin 2046.00
Zydus Lifesciences 1110.20
View more..